Your browser doesn't support javascript.
loading
Distinct neural networks predict cocaine versus cannabis treatment outcomes.
Lichenstein, Sarah D; Kohler, Robert; Ye, Fengdan; Potenza, Marc N; Kiluk, Brian; Yip, Sarah W.
Afiliación
  • Lichenstein SD; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. sarah.lichenstein@yale.edu.
  • Kohler R; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Ye F; Stripe, San Francisco, CA, USA.
  • Potenza MN; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Kiluk B; Child Study Center, Yale School of Medicine, New Haven, CT, USA.
  • Yip SW; Connecticut Mental Health Center, New Haven, CT, USA.
Mol Psychiatry ; 28(8): 3365-3372, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37308679
Treatment outcomes for individuals with substance use disorders (SUDs) are variable and more individualized approaches may be needed. Cross-validated, machine-learning methods are well-suited for probing neural mechanisms of treatment outcomes. Our prior work applied one such approach, connectome-based predictive modeling (CPM), to identify dissociable and substance-specific neural networks of cocaine and opioid abstinence. In Study 1, we aimed to replicate and extend prior work by testing the predictive ability of the cocaine network in an independent sample of 43 participants from a trial of cognitive-behavioral therapy for SUD, and evaluating its ability to predict cannabis abstinence. In Study 2, CPM was applied to identify an independent cannabis abstinence network. Additional participants were identified for a combined sample of 33 with cannabis-use disorder. Participants underwent fMRI scanning before and after treatment. Additional samples of 53 individuals with co-occurring cocaine and opioid-use disorders and 38 comparison subjects were used to assess substance specificity and network strength relative to participants without SUDs. Results demonstrated a second external replication of the cocaine network predicting future cocaine abstinence, however it did not generalize to cannabis abstinence. An independent CPM identified a novel cannabis abstinence network, which was (i) anatomically distinct from the cocaine network, (ii) specific for predicting cannabis abstinence, and for which (iii) network strength was significantly stronger in treatment responders relative to control particpants. Results provide further evidence for substance specificity of neural predictors of abstinence and provide insight into neural mechanisms of successful cannabis treatment, thereby identifying novel treatment targets. Clinical trials registation: "Computer-based training in cognitive-behavioral therapy web-based (Man VS Machine)", registration number: NCT01442597 . "Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management", registration number: NCT00350649 . "Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)", registration number: NCT01406899 .
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cannabis / Terapia Cognitivo-Conductual / Cocaína / Trastornos Relacionados con Sustancias / Trastornos Relacionados con Cocaína / Trastornos Relacionados con Opioides Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cannabis / Terapia Cognitivo-Conductual / Cocaína / Trastornos Relacionados con Sustancias / Trastornos Relacionados con Cocaína / Trastornos Relacionados con Opioides Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos